2,689
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Long-term efficacy and safety of secukinumab in real life: a 240 weeks multicenter study from Southern Italy

, , , , , , , , , , , , , , , , , , , & show all
Article: 2200868 | Received 20 Jan 2023, Accepted 30 Mar 2023, Published online: 16 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xujun Lu & Wenge Wang. (2023) Treatment of Erythrodermic Psoriasis in Children with Secukinumab: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16, pages 1977-1981.
Read now

Articles from other publishers (1)

Rawish Fatima & Nezam Altorok. (2023) Secukinumab-Induced Bullous Pemphigoid in a Patient With Psoriatic Arthritis. American Journal of Therapeutics Publish Ahead of Print.
Crossref